/
ARWR
$86.64+$1.05 (+1.23%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$12.3B
141M shares
52-week range
$18.14 – $95.49
89% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change+$25.91
Arrowhead Research Corporation
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
www.arrowheadpharma.com- Employees
- 711
- IPO / List date
- Feb 1, 1995
- HQ
- PASADENA, CA
Held by traders on TradeandTell
No one on the platform currently holds ARWR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,036,495 | $65.0M |
| Bridgewater Associatesas of 2026-03-31 | 95,552 | $6.0M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2011-11-17 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded ARWR yet.
